Advertisement
Singapore markets closed

  • Straits Times Index

    3,367.90
    +29.33 (+0.88%)
     

  • S&P 500

    5,475.09
    +14.61 (+0.27%)
     

  • Dow

    39,169.52
    +50.66 (+0.13%)
     

  • Nasdaq

    17,879.30
    +146.70 (+0.83%)
     

  • Bitcoin USD

    62,718.02
    +137.86 (+0.22%)
     

  • CMC Crypto 200

    1,342.07
    -2.43 (-0.18%)
     

  • FTSE 100

    8,134.06
    -32.70 (-0.40%)
     

  • Gold

    2,330.80
    -8.10 (-0.35%)
     

  • Crude Oil

    83.95
    +0.57 (+0.68%)
     

  • 10-Yr Bond

    4.4790
    +0.1360 (+3.13%)
     

  • Nikkei

    40,074.69
    +443.63 (+1.12%)
     

  • Hang Seng

    17,769.14
    +50.53 (+0.29%)
     

  • FTSE Bursa Malaysia

    1,597.96
    -0.24 (-0.02%)
     

  • Jakarta Composite Index

    7,125.14
    -14.48 (-0.20%)
     

  • PSE Index

    6,358.96
    -39.81 (-0.62%)
     

Alcon to pay Johnson & Johnson $199 million to settle eye-laser cases

Blake Brittain
Updated ·2-min read
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

By Blake Brittain

(Reuters) - Alcon Vision LLC will pay Johnson & Johnson's J&J Surgical Vision Inc $199 million to settle legal battles over intellectual property related to the companies' laser eye-surgery devices, Alcon said in a press release on Sunday.

Alcon said the one-time payment would resolve "various worldwide intellectual property disputes" and that the companies had reached a cross-licensing agreement.

Representatives for Johnson & Johnson did not immediately respond to a request for comment Monday on the settlement.

A copyright trial was set to begin this week in Delaware federal court over claims that Alcon stole software from J&J's iFS Laser system, used for LASIK vision correction and other surgeries, and utilized it in Alcon's LenSx system to treat cataracts. A J&J expert had argued that the company was entitled to at least $3.1 billion in damages.

ADVERTISEMENT

Both companies also accused each other of patent infringement in claims that had been put on hold by the Delaware court.

New Brunswick, New Jersey-based J&J's Catalys laser cataract surgery system competes with LenSx.

AMO Development LLC, which J&J acquired in 2017, sued Alcon in 2020 for allegedly stealing thousands of lines of its source code. It accused Alcon in a 2021 court filing of committing "theft and deception on a grand and shocking scale - of the type usually found in paperback novels and Hollywood movies, not real-life disputes between publicly traded companies."

J&J said Alcon left "smoking guns" in its code that showed its theft, like typographical errors identical to those in J&J's code and comments dating from before LenSx development started.

U.S. District Judge Colm Connolly said during a 2021 hearing that there was "overwhelming" evidence that Alcon intentionally copied J&J's code.

Fort Worth, Texas-headquartered Alcon had denied the allegations.

The case is AMO Development LLC v. Alcon Vision LLC, U.S. District Court for the District of Delaware, No. 1:20-cv-00842

(Reporting by Blake Brittain in Washington)